Royalty Pharma

NASDAQ: RPRX · Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT

Royalty Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
1.33B 1.7B 230.06M 1.24B
Depreciation & Amortization
n/a n/a 5.67M 23M
Stock-Based Compensation
2.34M 2.36M 2.17M 2.44M
Other Working Capital
60.22M 667K 35.12M 17.41M
Other Non-Cash Items
1.38B 1.28B 1.87B 767.22M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
53.38M 5.38M 32.66M -16.32M
Operating Cash Flow
2.77B 2.99B 2.14B 2.02B
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
-10.96M -12.54M -9.9M -34.85M
Purchase of Investments
-2.74B -2.12B -2.57B -3.59B
Sales Maturities Of Investments
118.36M 25.83M 1.55B 1.78B
Other Investing Acitivies
-49.32M 29.44M n/a -18.08M
Investing Cash Flow
-2.68B -2.07B -1.03B -1.87B
Debt Repayment
1.47B -1B n/a 1.27B
Common Stock Repurchased
-229.65M -304.76M n/a n/a
Dividend Paid
-376.46M -358.33M -333.32M -285.18M
Other Financial Acitivies
-503.97M -485.67M -611.53M -602.24M
Financial Cash Flow
361.14M -2.15B -944.86M 385.11M
Net Cash Flow
452.02M -1.23B 169.7M 532.37M
Free Cash Flow
2.77B 2.99B 2.14B 2.02B